Phase 3 Study to Compare the Efficacy and Safety of Eribulin With Dacarbazine in Subjects With Soft Tissue Sarcoma
Clinical trial NCT01327885 · COMPLETED
Trial details
- NCT number
- NCT01327885
- Sponsor
- Eisai Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2011-03-10
- Primary completion
- 2015-01-02
- Enrollment
- 452
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.